This atlas provides a practically applicable didatic case-based guide to the use of cardiac imaging in patient care during and after cancer therapy. It features detailed information on a variety of imaging modalities, including transesophageal echocardiography, magnetic resonance angiography and positron emission tomography. A range of actual patient presentations are included covering both diagnosis and management during curative and palliative surgery, as well as cancer pharmacotherapy with the use of drugs including Trastuzumab, Anthracycline, Cisplatin and Carboplatin. Topics relevant to survivorship are also described.
Atlas of Imaging in Cardio-Oncology enables the reader to develop a deep understanding of how to utilise a variety of imaging modalities used in cardio-oncology in a range of scenarios. It provides a critical and timely resource for the trainee and experienced cardiologist, oncologist and radiologist.
Richard M. SteingartWith more than 25 years of experience as a clinician, researcher, and educator in cardiovascular diseases, Dr Steingart joined Memorial Sloan Kettering as Chief of the Cardiology Service in 2003. MSK’s Cardiology Service is one of the world’s leading programs devoted exclusively to the management of cardiovascular diseases in cancer patients. The many facets of this program share a common goal: to facilitate the delivery of optimal cancer therapy in patients who are at risk for or who have existing heart disease. Careful communication with other members of the MSK treatment team ― including oncologists, surgeons, radiologists, radiation therapists, and medical subspecialists ― makes this possible. On a practical level, this effort reduces the risk of cancer patients developing heart disease, and allows more patients who have both cancer and heart disease to safely receive the optimal therapy for their cancer.
Jennifer E. Liu
Dr. Liu is the Director of the Cardiovascular Laboratories at Memorial Sloan Kettering Cancer Center. She has more than 20 years of experience in echocardiography and is a recognized leader in the field of cardiovascular imaging in Cardio Oncology. As an author of key expert consensus documents, she is dedicated to setting the standard of practice on the contemporary use of echocardiography in the management of patients during and after cancer therapy. Her clinical and research interests include the development of imaging-based strategies for early diagnosis and management of cardiotoxicity to optimize cardiovascular health in patients with cancer. She is the founder of the annual MSK Cardio Oncology symposium which provides a case-based curriculum to educate clinicians involved in the care of cancer patients.
